Veritas has established an exclusive partner alliance and investment in Cannevert Therapeutics, a high-level research & development company, with the main office on the University of British Columbia (UBC) campus. Cannevert has brought together a team of pharmacologists, anesthetists, and chemists with substantial prior success in drug development in both academia and industry. This alliance will provide Veritas with the needed technical ability to achieve its vision in terms of research, development & commercialization goals.
Cannevert Therapeutics Ltd.
Cannevert Therapeutics is a wholly owned subsidiary of Veritas Pharma. Cannevert is a high-level research & development company, with facilities at the University of British Columbia (UBC). Bringing together a highly accredited team of pharmacologists, anesthetists, and chemists with substantial prior success in both academia and industry, specifically in drug development. This alliance will provide Veritas with the needed technical ability to deliver on its research, development & commercialization goals.
3 Carbon Extractions Inc.
On April 16th, 2018, Veritas Pharma announced acquired 50% of 3 Carbon Extractions Inc., a premium extraction company, specializing in light hydrocarbon extractions.
3 Carbon Extractions is an extraction, research and technology company with the primary focus of light hydrocarbon extraction education & training for processing and methodology. 3 Carbon is the first official partner of ExtractionTek Solutions (ETS) to represent ETS in Canada which will become the first industrialized country to legalize cannabis for both medicinal and recreational usage. 3 Carbon and ETS are dedicated to bringing their experiences, high quality standards, knowledge regarding all facets of cannabis extraction including light hydrocarbon extraction.